Viewing Study NCT00180895


Ignite Creation Date: 2025-12-24 @ 1:55 PM
Ignite Modification Date: 2026-01-13 @ 4:31 PM
Study NCT ID: NCT00180895
Status: TERMINATED
Last Update Posted: 2006-09-11
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: Rituximab childhood
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View